Factors associated with treatment received by men diagnosed with prostate cancer in Queensland, Australia

Baade, Peter D.; Youlden, Danny R.; Gardiner, Robert A.; Ferguson, Megan; Aitken, Joanne F.; Yaxley, John; Chambers, Suzanne K.

doi:10.1111/j.1464-410x.2012.011533.x

Cited by 14 publications

(11 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A previous study has shown that men living in rural NSW and diagnosed with prostate cancer between 1993 and 2002 are less likely to have a radical prostatectomy after taking account of age and disease spread; 18 this is consistent with reports from Western Australia, 19 Queensland 20 and nationally 1 . Disease stage is more consistently recorded in patients who undergo surgery, and this may partly explain why the spread of disease was less likely to be unknown in major cities 21 …”

Section: Discussionsupporting

confidence: 71%

Geographic variation in prostate cancer survival in New South Wales

Luo

Smith

et al. 2014

Medical Journal of Australia

View full text Add to dashboard Cite

show abstract

Section: Discussionsupporting

confidence: 71%

Geographic variation in prostate cancer survival in New South Wales

Luo

Smith

et al. 2014

Medical Journal of Australia

View full text Add to dashboard Cite

show abstract

“…Limitations of the current study include the use of a nonrepresentative sample and the extent of study attrition over time. Specifically, the cohort was more likely to be have been diagnosed with intermediate than advanced prostate cancer compared to all men diagnosed with prostate cancer in Queensland during the same period . This means that generalisability to the population should be approached cautiously and that we were unable to explore the effect of stage of illness on outcomes.…”

Section: Discussionmentioning

confidence: 98%

“…These data are from a longitudinal study of men newly diagnosed with prostate cancer in Queensland . Ethical approval was obtained from the Queensland University of Technology Human Research Ethics Committee and ethics committees of 10 public hospitals in Queensland.…”

Section: Methodsmentioning

confidence: 99%

Trajectories of quality of life, life satisfaction, and psychological adjustment after prostate cancer

et al. 2017

Self Cite

View full text Add to dashboard Cite

BackgroundTo describe trajectories of health‐related quality of life (QoL), life satisfaction, and psychological adjustment for men with prostate cancer over the medium to long term and identify predictors of poorer outcomes using growth mixture models.MethodsOne‐thousand sixty‐four (82.4% response) men diagnosed with prostate cancer were recruited close to diagnosis and assessed over a 72‐month (6‐year) period with self‐report assessment of health‐related QoL, life satisfaction, cancer‐related distress, and prostate specific antigen anxiety. Urinary, bowel, and sexual function were also assessed using validated questionnaires.ResultsPoorer physical QOL was predicted by older age, lower education, lower income, comorbidities, and receiving hormone therapy. Lower life satisfaction was related to younger age, lower income, not being partnered, and comorbidities. Poorer psychological trajectories were predicted by younger age, lower income, comorbidities, and receiving radical prostatectomy or brachytherapy. Better urinary, bowel, and sexual function were related to better global outcomes over time. Anxiety about prostate specific antigen testing was rare.ConclusionsDistinct trajectories exist for medium‐ to long‐term QoL, life satisfaction, and psychological adjustment after prostate cancer; with age and socioeconomic deprivation playing a differential role in men's survivorship profile and the impact of functional status on outcomes increasing over time. These results reinforce the need for an appraisal of men's life course in addition to treatment side effects when planning survivorship care after cancer.

show abstract

“…The distance traveled for treatment was also not taken into account in this study, although it has been previously shown to affect RT choice in patients with prostate cancer. 35 Moreover, the results for Haitian-speaking patients may have more relevance in local disparities than at a national level, thereby limiting their generalizability.…”

Section: Discussionmentioning

confidence: 99%

Risk factors involved in treatment delays and differences in treatment type for patients with prostate cancer by risk category in an academic safety net hospital

Kan

Qureshi

Gupta

et al. 2018

Advances in Radiation Oncology

View full text Add to dashboard Cite

ObjectivesUnderstanding the drivers of delays from diagnosis to treatment can elucidate how to reduce the time to treatment (TTT) in patients with prostate cancer. In addition, the available treatments depending on the stage of cancer can vary widely for many reasons. This study investigated the relationship of TTT and treatment choice with sociodemographic factors in patients with prostate cancer who underwent external beam radiation therapy (RT), radical prostatectomy (RP), androgen deprivation therapy (ADT), or active surveillance (AS) at a safety-net academic medical center.Methods and materialsA retrospective review was performed on 1088 patients who were diagnosed with nonmetastatic prostate cancer between January 2005 and December 2013. Demographic data as well as data on TTT, initial treatment choice, American Joint Committee on Cancer stage, and National Comprehensive Cancer Network risk categories were collected. Analyses of variance and multivariable logistic regression models were performed to analyze the relationship of these factors with treatment choice and TTT.ResultsAge, race, and marital status were significantly related to treatment choice. Patients who were nonwhite and older than 60 years were less likely to undergo RP. Black patients were 3.8 times more likely to undergo RT compared with white patients. The median TTT was 75 days. Longer time delays were significant in patients of older age, nonwhite race/ethnicity, non-English speakers, those with noncommercial insurance, and those with non-married status. The average TTT of high-risk patients was 25 days longer than that of low-risk patients. Patients who underwent RT had an average TTT that was 34 days longer than that of RP patients.ConclusionsThe treatment choice and TTT of patients with prostate cancer are affected by demographic factors such as age, race, marital status, and insurance, as well as clinical factors including stage and risk category of disease.

show abstract

Factors associated with treatment received by men diagnosed with prostate cancer in Queensland, Australia

Cited by 14 publications

References 23 publications

Geographic variation in prostate cancer survival in New South Wales

Geographic variation in prostate cancer survival in New South Wales

Trajectories of quality of life, life satisfaction, and psychological adjustment after prostate cancer

Risk factors involved in treatment delays and differences in treatment type for patients with prostate cancer by risk category in an academic safety net hospital

Contact Info

Product

Resources

About